Company: PTPI
Filing Date: 2025-05-15
Form Type: SCHEDULE 13G/A
Source: 0000930413-25-001822
Chunk: 1

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-05-15
Form: SCHEDULE 13G/A
Chunk 1
---
 of Common Stock issuable upon conversion of shares of Preferred Stock held directly by IMF at a conversion price of $0.24 and 352,641 shares of Common Stock issuable upon conversion of shares of Preferred Stock held directly by ICIG at a conversion price of $0.24 (collectively, the "Preferred Shares"), all of which are subject to a 4.99% Beneficial Ownership Blocker.                       
 The Warrants and Preferred Shares contain provisions which precludes the exercise of such Warrants or the conversion of such Preferred Shares to the extent that, following exercise or conversion, as applicable, the holder, together with its affiliates and other attribution parties, would own more than 4.99% of the Common Stock outstanding with respect to the Preferred Shares and certain Warrants and 9.99% of the Common Stock outstanding with respect to certain Warrants (collectively, the "Beneficial Ownership Blockers"). The Reporting Persons are currently prohibited from exercising certain Warrants to the extent that such exercise would result in beneficial ownership of more than 5,939,954   shares of Common Stock or converting the Preferred Shares or exercising certain Warrants to the extent that such exercise or conversion, as applicable, would result in beneficial ownership of more than 2,810,862 shares of Common Stock. 
 The shares of Common Stock listed as beneficially owned in Rows 6, 8 and 9 of the cover pages for each Reporting Person and the percentage set forth in Row 11 of the cover page for each Reporting Person give effect to the Beneficial Ownership Blockers. Consequently, as of the date of the event which requires the filing of this statement, the Reporting Persons were not able to exercise all of the Warrants or convert the Preferred Shares due to the Beneficial Ownership Blockers. Each the Reporting Persons disclaims beneficial ownership over the securities listed except to the extent of their pecuniary interest therein.                                                                                                                                                                                                                                                                                                                          |
| (b)     | Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentages of the securities of the Issuer beneficially owned by such Reporting Person as of the date of the event which requires filing of this statement and is incorporated herein by reference. Due to the Beneficial Ownership Blockers, the collective beneficial ownership percentage of the Reporting Persons was 9.99% as of the date of the event which requires filing of this statement. Such percentage is based upon the sum of (i) 53,519,045 shares of the Issuer